PALISADE CAPITAL MANAGEMENT, LP - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 140 filers reported holding HERON THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.8%.

Quarter-by-quarter ownership
PALISADE CAPITAL MANAGEMENT, LP ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,234,280
-11.9%
4,110,951
-0.8%
0.12%
-7.8%
Q2 2023$4,806,633
-19.8%
4,143,649
+4.4%
0.13%
-21.0%
Q1 2023$5,995,132
-36.7%
3,970,286
+4.9%
0.16%
-36.2%
Q4 2022$9,464,737
-33.8%
3,785,895
+11.7%
0.25%
-37.3%
Q3 2022$14,300,000
+72.9%
3,388,632
+14.3%
0.40%
+80.8%
Q2 2022$8,270,000
-50.5%
2,964,074
+1.5%
0.22%
-41.7%
Q1 2022$16,709,000
-39.7%
2,921,107
-3.7%
0.38%
-31.6%
Q4 2021$27,702,000
+4.0%
3,034,172
+21.8%
0.56%
-3.4%
Q3 2021$26,635,000
-5.7%
2,491,583
+37.0%
0.58%
-8.8%
Q2 2021$28,233,000
+63.7%
1,819,131
+71.0%
0.64%
+57.3%
Q1 2021$17,243,000
-8.5%
1,063,734
+19.4%
0.40%
-16.0%
Q4 2020$18,850,000
+55.0%
890,618
+8.5%
0.48%
+33.9%
Q3 2020$12,160,000
+22.4%
820,539
+21.5%
0.36%
+13.9%
Q2 2020$9,935,000
+26.3%
675,365
+0.8%
0.32%
+13.7%
Q1 2020$7,869,000
-43.7%
670,238
+12.6%
0.28%
-30.0%
Q4 2019$13,987,000
+39.8%
595,198
+10.1%
0.40%
+29.7%
Q3 2019$10,005,000
+6.1%
540,819
+6.6%
0.31%
+5.2%
Q2 2019$9,433,000
+0.3%
507,421
+31.9%
0.29%
-3.6%
Q1 2019$9,403,000
+19.4%
384,741
+26.7%
0.30%
+4.5%
Q4 2018$7,876,000303,6060.29%
Other shareholders
HERON THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TANG KEVIN C 760$783100.00%
Velan Capital Investment Management LP 6,986,744$7,196,3465.80%
Tejara Capital Ltd 2,109,681$2,172,9711.23%
JW Asset Management, LLC 2,407,418$2,479,6411.07%
Rubric Capital Management LP 26,713,503$27,514,9081.03%
GREAT POINT PARTNERS LLC 4,737,368$4,879,4890.89%
Orchard Capital Management, LLC 2,142,823$2,207,1080.82%
Clearline Capital LP 6,149,842$6,334,3380.54%
CM Management, LLC 450,000$463,5000.49%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 327,450$337,2740.48%
View complete list of HERON THERAPEUTICS INC shareholders